SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001787306-21-000029
Filing Date
2021-11-04
Accepted
2021-11-04 16:05:34
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20211104.htm   iXBRL 8-K 35445
2 EX-99.1 pressreleaseex991q32021.htm EX-99.1 81811
6 a1a82.jpg GRAPHIC 25530
  Complete submission text file 0001787306-21-000029.txt   306669

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20211104.xsd EX-101.SCH 1887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20211104_lab.xml EX-101.LAB 26153
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20211104_pre.xml EX-101.PRE 13571
7 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20211104_htm.xml XML 11670
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 211379879
SIC: 2834 Pharmaceutical Preparations